|
|
Post by robsacher on Dec 30, 2015 22:01:04 GMT -5
As 2015 comes to a close, I invite folks to speculate at what p/s will our favorite little company be trading on this date next year?
Pick a number and please mention why you support that number, i.e. Afrezza approval in Europe or China, improved tier 2 insurance status, Technosphere application for second drug, or, if you think the worst, will MannKind even exist and be trading...
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Dec 30, 2015 23:18:51 GMT -5
As 2015 comes to a close, I invite folks to speculate at what p/s will our favorite little company be trading on this date next year? Pick a number and please mention why you support that number, i.e. Afrezza approval in Europe or China, improved tier 2 insurance status, Technosphere application for second drug, or, if you think the worst, will MannKind even exist and be trading...Cant really speculate beyond sales ramping up further. We will probably see 1000 weekly rx soon. Further improvement in insurance coverage. And I will additionally speculate that SYN gets there stuff together or we shop Afrezza to the highest bidder. A scenerio which could cause initial shock but, eventual share price improvement. All in all a sense of opptomism. And stilling crossing fingers for a buy in from Sanofi. |
|
|
|
Post by garrett on Dec 31, 2015 8:02:50 GMT -5
That's difficult - I can say with 100% certainly it will be higher than today!
|
|
|
|
Post by spiro on Dec 31, 2015 8:38:05 GMT -5
Well, my good friend Spiro says that if even 50% of the so called dots that we have been connecting exist, MNKD will be selling for at least $14.17. Spiro also told me that there were small dots and big dots, he said to keep an eye on the big dots in 2016.
John here, Spiro is still sleeping
|
|
|
|
Post by bioexec25 on Dec 31, 2015 8:45:31 GMT -5
Impossible question but ok it's New Years Eve so what the heck.
I'll go with the price it was a year ago ($5.33) + 50% growth ($7.995) for the reasons that we've discussed, eg TS, Afrezza global launch, Tier 2 no strings, scripts, cash resolved, etc etc. If all those happen then it's likely pushing $10.
I'll add that while not a huge % chance we may be counting this in a different or with two stock tickers. ;-))
Happy New Year to all members. Have a safe and prosperous 2016.
|
|
|
|
Post by kball on Dec 31, 2015 8:52:50 GMT -5
No freaking idea.
Has to slightly more than triple for me to break even. (That i do know)
|
|
|
|
Post by falconquest on Dec 31, 2015 12:37:38 GMT -5
As 2015 comes to a close, I invite folks to speculate at what p/s will our favorite little company be trading on this date next year? Pick a number and please mention why you support that number, i.e. Afrezza approval in Europe or China, improved tier 2 insurance status, Technosphere application for second drug, or, if you think the worst, will MannKind even exist and be trading...We do a lot of speculating here because well, that's all we have. So why not join the fray. I will offer two scenarios. First, we stay the course, scripts improve, insurance coverage improves, DTC kicks in etc. and we find ourselves in the $8.00 range. The other scenario is that Mannkind spins off Afrezza to Sanofi and announces one new partnership for Technosphere and we find ourselves at the end of 2016 in the $18.00 range. Those are my optimistic scenarios. |
|
|
|
Post by mnholdem on Dec 31, 2015 12:58:24 GMT -5
I know what some people are predicting:
What's my prediction for 2016? MannKind will win the fight against those who bashed the company in the early rounds. |
|
|
|
Post by trondisc on Dec 31, 2015 15:08:50 GMT -5
$5.00 if we're lucky. $10+ if we receive solicitation outside of Sanofi the sandbagger. One thing *is for sure*, us Longs are stuck in low single digit purgatory for at least another 6 months. ;(
|
|
|
|
Post by dreamboatcruise on Dec 31, 2015 18:12:26 GMT -5
As 2015 comes to a close, I invite folks to speculate at what p/s will our favorite little company be trading on this date next year? Pick a number and please mention why you support that number, i.e. Afrezza approval in Europe or China, improved tier 2 insurance status, Technosphere application for second drug, or, if you think the worst, will MannKind even exist and be trading...My crystal ball says 1 and 5. It doesn't have decimal points so not sure if that is $1.50, $15 or $0.15. I'm sure I could rationalize any of those based on potential outcomes and how little info we have to judge their probabilities. |
|
|
|
Post by mnkdnewbie on Dec 31, 2015 18:22:05 GMT -5
I just added 700 shares at 1.45, took an hour to fill the whole order.....
|
|
|
|
Post by mindovermatter on Dec 31, 2015 18:33:44 GMT -5
As 2015 comes to a close, I invite folks to speculate at what p/s will our favorite little company be trading on this date next year? Pick a number and please mention why you support that number, i.e. Afrezza approval in Europe or China, improved tier 2 insurance status, Technosphere application for second drug, or, if you think the worst, will MannKind even exist and be trading...All I want for 2016 is for Afrezza to finally find traction, get overly positive coverage, see Adam Fraudstain apologize for being wrong and see a few big TS deals get inked. Those should help lift the stock price. |
|
|
|
Post by suebeeee1 on Dec 31, 2015 20:50:27 GMT -5
OK...my guess is $29.45 as of December 31, 2016. Rational behind this?? Absolutely nothing. But I know it works and when a critical mass knows it works, this will set on fire. I was chatting with my husband, who was teasing me (ok a bit more than teasing) about this "loser" stock. Clearly the worst in our portfolio this year. While he is, as everyone know, as stong proponent of the product, he hates the sp and would like it gone from our investment portfolio. We were discussing the trials that SNY is doing in Germany with kids and how once you get people used to inhaling rather than injecting, they will never change. Of course, we can't wait for 4 year old kids to grow up with Afrezza, just too long to keep MNKD afloat. Then we began discussion our journey attempting to get the drug and our original doctor telling us that he would LOVE it if most of his diabetic patients had A1c as low as my husbands was before Afrezza: 7.8. Most of his patients had A1c in excess of 10! Why? Because they didn't want to go to needles and were postponing the inevitable with layers upon layers of oral drugs with all sorts of side effects OR they were as lazy as His Highness and the doc knew that he wouldn't do the calculations of his carbs and proteins before injecting an appropriate amount of insulin (and he is a numbers person to boot) and he wouldn't do additional pricking and testing to insure that his blood glucose did not go too low to prevent serious hypoglycemia problems. When he realized how BIG that Type 2 UNDERTREATED market was, the light bulb went on. He stopped bitching about my lousy investment. "We can wait" he said. Yup, if he gets it, just think what will happen when the doctors finally get it. Which brings me back to the subject of this topic. When they do get it, it will be like the hundred monkey theory. Everyone will get it at once. $29.45! If we get that, you all need to take me to dinner  |
|
|
|
Post by kball on Dec 31, 2015 20:56:37 GMT -5
OK...my guess is $29.45 as of December 31, 2016. Rational behind this?? Absolutely nothing. But I know it works and when a critical mass knows it works, this will set on fire. I was chatting with my husband, who was teasing me (ok a bit more than teasing) about this "loser" stock. Clearly the worst in our portfolio this year. While he is, as everyone know, as stong proponent of the product, he hates the sp and would like it gone from our investment portfolio. We were discussing the trials that SNY is doing in Germany with kids and how once you get people used to inhaling rather than injecting, they will never change. Of course, we can't wait for 4 year old kids to grow up with Afrezza, just too long to keep MNKD afloat. Then we began discussion our journey attempting to get the drug and our original doctor telling us that he would LOVE it if most of his diabetic patients had A1c as low as my husbands was before Afrezza: 7.8. Most of his patients had A1c in excess of 10! Why? Because they didn't want to go to needles and were postponing the inevitable with layers upon layers of oral drugs with all sorts of side effects OR they were as lazy as His Highness and the doc knew that he wouldn't do the calculations of his carbs and proteins before injecting an appropriate amount of insulin (and he is a numbers person to boot) and he wouldn't do additional pricking and testing to insure that his blood glucose did not go too low to prevent serious hypoglycemia problems. When he realized how BIG that Type 2 UNDERTREATED market was, the light bulb went on. He stopped bitching about my lousy investment. "We can wait" he said. Yup, if he gets it, just think what will happen when the doctors finally get it. Which brings me back to the subject of this topic. When they do get it, it will be like the hundred monkey theory. Everyone will get it at once. $29.45! If we get that, you all need to take me to dinner Sue clearly hitting the booze early new years eve |
|
|
|
Post by bradleysbest on Dec 31, 2015 20:59:31 GMT -5
$29.45 will get you & your husband dinner at Lawry's on La Cienega! Let's go DeSisto!
|
|
